Back to BT Blue Trust, Inc.

TGTXTGTX

Showing 8 of 15 quarters

Position history for BTBlue Trust, Inc.'s holdings in TG Therapeutics, Inc.

Yes. Blue Trust holds 3 shares of TGTX (TG Therapeutics), worth $167, as of its Q3 2026 13F filing. It reduced the position by 191 shares (-98.5%) from Q2 2026. Blue Trust has held TGTX since Q2 2024, across 10 quarterly 13F filings.

Current Value

$167

Current Shares

3

Total Value Change

-$56,632

Total Shares Change

-1,884

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
3
-98.5%
$1670.0%$55.78
0
2026-Q2
Decreased
194
-37.4%
$10,6580.0%$54.94
0
2026-Q1
Unchanged
310
0.0%
$10,2980.0%$33.22
0
2025-Q4
Decreased
310
-79.4%
$9,2410.0%$29.81
0
2025-Q3
Unchanged
1,507
0.0%
$54,4400.0%$36.13
0
2025-Q2
Decreased
1,507
-29.0%
$54,2370.0%$35.99
0
2025-Q1
Increased
2,123
+12.5%
$83,7100.0%$39.43
24
2024-Q4
Increased
1,887
+24.5%
$56,7990.0%$30.10
25

Optional analytics helps us improve. How it’s used